Diabetic kidney disease (DKD), as the most common complication of diabetes mellitus (DM),
is the major cause of end-stage renal disease (ESRD). Renal interstitial fibrosis is a crucial …

Diabetic nephropathy (DN) is a common kidney disease in people with diabetes, which is
also a serious microvascular complication of diabetes and the main cause of end-stage …

Fibrosis refers to the scarring and hardening of tissues, which results from a failed immune
system-coordinated wound healing response to chronic organ injury and which manifests …

Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the
most common cause of end stage renal disease (ESRD). Renal fibrosis is the final …

Diabetic nephropathy (DN) is a major cause of end‐stage renal disease (ESRD).
Glycyrrhizic acid (GA) is an effective inhibitor of reactive oxygen species (ROS) production …

Fibrosis can occur in all major organs with relentless progress, ultimately leading to organ
failure and potentially death. Unfortunately, current clinical treatments cannot prevent or …

We aimed to explore the active ingredients and molecular mechanism of Tripterygium
wilfordii (TW) in the treatment of diabetic nephropathy (DN) through network pharmacology …

Background: Triptolide (TP) is a major active component of colquhounia root tablet, which
has been long been used in China to treat diabetic nephropathy (DN) due to its marked anti …

Diabetic nephropathy (DN) is a common type of end-stage renal disease and glomerular
mesangial cells (GMCs) are widely used as a cell model for DN. This study firstly …

Background Diabetic kidney disease (DKD) is a severe microvascular complication of
diabetes mellitus that can lead to end-stage renal disease. Colquhounia root tablet (CRT) …